Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding Anlon healthcare share price prediction, Anlon healthcare share price history, Anlon Healthcare IPO share price, Anlon Healthcare share price screener, Anlon Healthcare share price Target 2030, Anlon Healthcare share price NSE, and much more. Furthermore, this page provides details on Anlon Healthcare‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
Anlon Healthcare Company Information
| Number of employees |
101 (2025) |
| Founded | 2013 |
| Headquarters | India |
| Subsidiaries | Remember India Health Links Private Limited |
Anlon Healthcare Share Price Target Overview
- Current Price – 13.74
- Open – 14.05
- High – 14.24
- Low – 13.68
- Mkt cap – 728.71Cr
- P/E ratio – 20.52
- 52-wk high – 17.28
- 52-wk low – 9.08
- Dividend – N/A
- Qtrly div amt – N/A
Anlon Healthcare Share Price Chart
Anlon Healthcare Share Price Target Tomorrow (Prediction)
| Anlon Healthcare Share Price Target Years | Anlon Healthcare Share Price Target |
| 2026 | ₹20 |
| 2027 | ₹25 |
| 2028 | ₹30 |
| 2029 | ₹35 |
| 2030 | ₹40 |
Anlon Healthcare Share Price Target 2026
The target for Anlon Healthcare’s share price in 2026 is projected to range between ₹19 and ₹20. As of mid of May 2026, Anlon Healthcare’s share price stood at ₹13.74. Compared to the previous year, Anlon Healthcare’s share price has witnessed an increase this year.
Anlon Healthcare Share Price Target 2027
The target for Anlon Healthcare’s share price in 2027 is projected to range between ₹24 and ₹25. On 22 May 2026, Anlon Healthcare Share price NSE is 13.74 INR. Compared to last year, no significant difference has been observed in the share price of Anlon Healthcare. The share price has increased by approximately 4-5 rupees.
Anlon Healthcare Share Price Target 2030
The target for Anlon Healthcare’s share price in 2030 is projected to range between ₹39 and ₹40. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Read Also:- Arisinfra Solutions Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Anlon Healthcare Shareholding Pattern
| Promoter | 52.68% |
| FII | 0.32% |
| DII | 4.60% |
| Retails & Others | 42.40% |
| Mutual Funds | 0% |
Income Statement Of Anlon Healthcare
|
All values in INR
|
Dec 2024
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
|---|---|---|---|---|
|
Revenue
|
93.61M
|
332.97M
|
522.01M
|
355.78M
|
|
Cost of goods sold
|
56.47M
|
242.23M
|
329.58M
|
200.71M
|
|
Cost of revenue
|
56.47M
|
242.23M
|
329.58M
|
200.71M
|
|
Research and development expenses
|
–
|
–
|
–
|
–
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
12.23M
|
12.25M
|
10.62M
|
17.13M
|
|
Operating expense
|
31.38M
|
32.65M
|
59.57M
|
35.18M
|
|
Total operating expenses
|
87.84M
|
274.88M
|
389.16M
|
235.89M
|
|
Operating income
|
5.77M
|
58.10M
|
132.86M
|
119.89M
|
|
Other non operating income
|
189.00K
|
117.00K
|
272.00K
|
2.03M
|
|
EBT including unusual items
|
-2.91M
|
50.04M
|
124.47M
|
106.13M
|
|
EBT excluding unusual items
|
-2.91M
|
50.04M
|
124.47M
|
106.13M
|
|
Income tax expense
|
21.95M
|
14.57M
|
31.30M
|
54.61M
|
|
Effective tax rate
|
-753.90%
|
29.12%
|
25.14%
|
51.46%
|
|
Other operating expenses
|
19.14M
|
16.13M
|
44.44M
|
14.51M
|
|
Net income
|
-24.86M
|
35.47M
|
93.17M
|
51.52M
|
|
Net profit margin
|
-26.55%
|
10.65%
|
17.85%
|
14.48%
|
|
Earnings per share
|
–
|
–
|
–
|
–
|
|
Interest and investment income
|
–
|
–
|
–
|
–
|
|
Interest expense
|
-8.87M
|
-8.17M
|
-8.66M
|
-15.78M
|
|
Net interest expenses
|
-8.87M
|
-8.17M
|
-8.66M
|
-15.78M
|
|
Depreciation and amortization charges
|
–
|
4.27M
|
4.52M
|
3.53M
|
|
EBITDA
|
10.48M
|
62.36M
|
137.25M
|
124.33M
|
|
Gain or loss from assets sale
|
–
|
–
|
–
|
–
|
Read Also:- Dev Accelerator Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.